Oh OK. I understand.If I was confused by your argument it is because I can see it is still a false argument.You are arguing that the FDA has gone against their SOPs in accepting the BLA by using an example post BLA acceptance CRL.
Your point is stupider than I thought it was. I'm not going to bother looking up whether the evaluation process was "alinear" because it seems to be irrelevant to the argument that the FDA wouldn't have accepted the BLA if they felt the CRL wasn't actually addressed.
2023 The Final Countdown, page-2025
-
- There are more pages in this discussion • 1,379 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.8¢ |
Change
0.008(0.77%) |
Mkt cap ! $1.118B | |||
| Open | High | Low | Value | Volume |
| 96.0¢ | 99.0¢ | 95.5¢ | $3.599M | 3.688M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 57 | 113092 | 97.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 98.0¢ | 118507 | 17 |
View Market Depth
| Last trade - 14.10pm 27/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |